Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

1,356 recalls, newest first

Class II · Moderate risk

CVS Health

CGMP Deviations: products manufactured under conditions that could impact its product quality.

Terminated cGMP deviation Product Quest Manufacturing LLC D-0034-2019
Class II · Moderate risk

CVS Health

CGMP Deviations: products manufactured under conditions that could impact its product quality.

Terminated cGMP deviation Product Quest Manufacturing LLC D-0033-2019
Class II · Moderate risk

CVS Health

CGMP Deviations: products manufactured under conditions that could impact its product quality.

Terminated cGMP deviation Product Quest Manufacturing LLC D-0032-2019
Class II · Moderate risk

CVS Health

CGMP Deviations: products manufactured under conditions that could impact its product quality.

Terminated cGMP deviation Product Quest Manufacturing LLC D-0031-2019
Class II · Moderate risk

CVS Health

CGMP Deviations: products manufactured under conditions that could impact its product quality.

Terminated cGMP deviation Product Quest Manufacturing LLC D-0030-2019
Class II · Moderate risk

CareOne

CGMP Deviations: products manufactured under conditions that could impact its product quality.

Terminated cGMP deviation Product Quest Manufacturing LLC D-0029-2019
Class II · Moderate risk

10 mg/mL Rocuronium Bromide

CGMP deviations: Product was released while a hood certification discrepancy was being investigated.

Terminated cGMP deviation PharMEDium Services, LLC D-1045-2018
Class II · Moderate risk

5 mg/mL Ephedrine Sulfate

CGMP deviations: Product was released while a hood certification discrepancy was being investigated.

Terminated cGMP deviation PharMEDium Services, LLC D-1044-2018
Class II · Moderate risk

10 mcg/mL Fentanyl Citrate

CGMP deviations: Product was released while a hood certification discrepancy was being investigated.

Terminated cGMP deviation PharMEDium Services, LLC D-1043-2018
Class II · Moderate risk

Monsel's Solution

CGMP Deviations: The manufacturer of this product recalled because they were not manufactured under current good manufacturing practices.

Terminated cGMP deviation Medgyn Products, Inc. NDC 42721-112-08 D-0917-2018
Class II · Moderate risk

Monsel's Solution

CGMP Deviations: Products not manufactured under current good manufacturing practices.

Terminated cGMP deviation BioDiagnostic International NDC 42721-112-08 D-0874-2018
Class II · Moderate risk

Loxapine Capsules

CGMP Deviations

Terminated cGMP deviation Mylan Pharmaceuticals Inc. NDC 0378-7050-01 D-0825-2018
Class II · Moderate risk

Loxapine Capsules

CGMP Deviations

Terminated cGMP deviation Mylan Pharmaceuticals Inc. NDC 0378-7025-01 D-0824-2018
Class II · Moderate risk

Amlodipine and Benazapril HCL Capsules

cGMP Deviations; cleaning processes for equipment used to manufacture the specified batches was not followed according to procedure

Terminated cGMP deviation Mylan Pharmaceuticals Inc. NDC 0378-6899-01 D-0820-2018

Recalls by year